Concentra Group Holdings Parent, Inc. vs NeoGenomics Laboratories, Inc.
Concentra Group Holdings Parent, Inc. (CON) and NeoGenomics Laboratories, Inc. (NEO) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $5.29B
- Last close
- $41.84
- 12 months
- +115.0%
- Market value
- $1.92B
- Last close
- $14.82
- 12 months
- +39.8%
At a glance
- The biggest part of NeoGenomics Laboratories, Inc.'s revenue is Client direct billing, 71% of the total in its last annual report.
- By market value, Concentra Group Holdings Parent, Inc. ($5.3B) is about 2.8 times NeoGenomics Laboratories, Inc. ($1.9B).
- Over the last 12 months Concentra Group Holdings Parent, Inc.'s share price moved +115.0% and NeoGenomics Laboratories, Inc.'s +39.8%; against the S&P 500 that is +109.3 points and +34.1 points.
- In their last fiscal years Concentra Group Holdings Parent, Inc. kept 7.7% of revenue as net income and NeoGenomics Laboratories, Inc. -14.9%.
- In the last 90 days insiders reported 0 open-market purchases at Concentra Group Holdings Parent, Inc. and 0 at NeoGenomics Laboratories, Inc.; members of Congress disclosed 0 trades in Concentra Group Holdings Parent, Inc. and 1 in NeoGenomics Laboratories, Inc..
- Next results: Concentra Group Holdings Parent, Inc. not announced, NeoGenomics Laboratories, Inc. Feb 15, 2027.
How each one makes money: Concentra Group Holdings Parent, Inc. revenue
Share prices on one chart
Concentra Group Holdings Parent, Inc. and NeoGenomics Laboratories, Inc., and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Concentra Group Holdings Parent, Inc. CONNYSE · Health Care Services | NeoGenomics Laboratories, Inc. NEONASDAQ · Health Care Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $5.29B | $1.92B |
| Revenue, last fiscal year | $2.16B | $727M |
| Net income, last fiscal year | $166M | −$108M |
| Net marginNet income as a share of revenue | 7.7% | -14.9% |
| Free cash flow | $197M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Common questions
How is Concentra Group Holdings Parent, Inc. different from NeoGenomics Laboratories, Inc.?
Concentra Group Holdings Parent, Inc. (CON) is in Health Care Services on NYSE, with $2.16B of revenue in its last fiscal year and a net margin of 7.7%. NeoGenomics Laboratories, Inc. (NEO) is in Health Care Services on NASDAQ, with $727M of revenue in its last fiscal year and a net margin of -14.9%. The biggest part of NeoGenomics Laboratories, Inc.'s revenue is Client direct billing, 71% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Concentra Group Holdings Parent, Inc. and NeoGenomics Laboratories, Inc. compare in size?
Concentra Group Holdings Parent, Inc. has the larger market value: Concentra Group Holdings Parent, Inc. $5.29B and NeoGenomics Laboratories, Inc. $1.92B, at the last close.
Whose share price rose more over the last 12 months, CON or NEO?
Over the last 12 months Concentra Group Holdings Parent, Inc. moved +115.0% and NeoGenomics Laboratories, Inc. +39.8%. Past price moves say nothing about the future.
Which has had more insider buying, Concentra Group Holdings Parent, Inc. or NeoGenomics Laboratories, Inc.?
Since 2006, NeoGenomics Laboratories, Inc. insiders reported 38 open-market purchases against 0 for Concentra Group Holdings Parent, Inc.. These are counts of what was filed, not a view on either stock.
Do members of Congress trade CON or NEO?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Concentra Group Holdings Parent, Inc. pageNeoGenomics Laboratories, Inc. pageRare insider trades this weekAll comparisons
https://oqro.io/compare/con-vs-neo

